/
/
/

Gufic Biosciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹261 Cr₹252 Cr₹231 Cr₹237 Cr₹224 Cr₹205 Cr₹208 Cr₹204 Cr₹203 Cr₹195 Cr₹202 Cr₹215 Cr
₹46 L-₹1 Cr₹79 L₹2 Cr₹93 L₹39 L₹2 Cr₹11 L₹1 Cr₹88 L₹42 L₹33 L
₹261 Cr₹251 Cr₹232 Cr₹239 Cr₹225 Cr₹205 Cr₹210 Cr₹204 Cr₹204 Cr₹196 Cr₹202 Cr₹215 Cr
₹222 Cr₹212 Cr₹206 Cr₹207 Cr₹198 Cr₹186 Cr₹178 Cr₹170 Cr₹171 Cr₹165 Cr₹169 Cr₹180 Cr
₹47 Cr₹46 Cr₹34 Cr₹40 Cr₹34 Cr₹27 Cr₹36 Cr₹39 Cr₹37 Cr₹35 Cr₹37 Cr₹40 Cr
₹9 Cr₹9 Cr₹8 Cr₹10 Cr₹9 Cr₹8 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr
₹30 Cr₹29 Cr₹18 Cr₹23 Cr₹17 Cr₹11 Cr₹26 Cr₹29 Cr₹28 Cr₹27 Cr₹30 Cr₹31 Cr
₹22 Cr₹22 Cr₹12 Cr₹17 Cr₹13 Cr₹8 Cr₹19 Cr₹22 Cr₹21 Cr₹20 Cr₹22 Cr₹23 Cr

Share Price Live Stats

Open (₹)440.50
Volume (₹)52,482.00
High (₹)447.20
Upper Circuit527.20
Low (₹)437.15
Lower Circuit351.50
Prev Close439.35
52W High (₹)453.95
Price443.00
52W Low (₹)268.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)4414.94 Cr
Div. Yield (%)0.02
PE Ratio60.10
Debt to Equity0.58
Price to Book4.14
Book Value66.31
EPS (TTM)7.33
Face Value1.00
ROE (%)10.14

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
GUFICBIONSE
LTP
1W Low
1W High
Market cap (₹)
1899.4-20.6 (-1.07%)
1896.80
1984.80
4,56,833Cr
9135-104 (-1.13%)
9087
9467
2,45,426Cr
4839-211 (-4.18%)
4823
5066
1,87,320Cr
1130-61 (-5.12%)
1125.10
1187
1,13,217Cr
1380.1-43.4 (-3.05%)
1376
1426.10
1,12,212Cr
1843.4-95.1 (-4.91%)
1811.70
1949
1,01,155Cr
2109.2-62.3 (-2.87%)
2107.20
2192
97,626Cr
2330.9-52 (-2.18%)
2327.30
2419.20
96,859Cr
1157.7-20.3 (-1.72%)
1154.40
1179.90
96,406Cr
1652.3+7 (0.43%)
1622.60
1717
93,614Cr
443+36.7 (9.03%)
395.05
453.95
4,415Cr

Key Highlights of Gufic Biosciences Ltd’s P&L

In 2026-03-31, Gufic Biosciences Ltd reported total revenue of ₹946.66Cr, compared with ₹823.43Cr in 2025-03-31, reflecting Gufic Biosciences Ltd turnover.

Depreciation was ₹30.83Cr and finance costs were ₹36.61Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹86.55Cr in 2026-03-31 as compared to ₹94.14Cr in 2025-03-31.

Net Profit (PAT) was ₹64.21Cr in 2026-03-31 compared with ₹69.65Cr in 2025-03-31.

Earnings per share (EPS) were ₹6.40 in 2026-03-31, compared with ₹6.95 in 2025-03-31.